The Duke ADHD Program conducts leading-edge research and patient studies to better understand and treat attention deficit hyperactivity disorder (ADHD).

Our research studies offer free, experimental care to patients with a current or suspected ADHD diagnosis.

What to Expect

Before the study starts we will clearly explain all study procedures and answer any of your questions. We require you to sign a consent form that clearly defines study expectations. Since your participation is completely voluntary, you can stop participating at any time.

Time Requirements

Studies vary in length and time requirements, and these will be clearly communicated to you before you begin participation.

Participant Requirements

In general, patients should meet the following requirements:

• Healthy with no major past medical problems
• Not on long-term medication (other than ADHD medication which may have to be suspended for the duration of the trial)
• No drug or alcohol abuse

Study Types

Studies can examine either behavioral modification interventions or medications.

Medication studies involve patients taking medications that may or may not be currently available on the market, including stimulant medications, non-stimulant alternatives, placebos, and other novel drugs. These medications may be given at varying dosages.

Next Steps

At the end of the study, we will work with you to determine the most appropriate next steps for your care.

These studies are funded either by the National Institutes of Health (NIH) or pharmaceutical companies.

Current ADHD Clinical Trials

ADHD Adolescent Medication Study